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ABSTRACT 
Trypanosoma brucei causes African 
trypanosomiasis and contains three full-length 
oligosaccharyltransferase (OST) genes; two of 
which, TbSTT3A and TbSTT3B, are expressed 
in the bloodstream form of the parasite. These 
OSTs have different peptide acceptor and lipid-
linked oligosaccharide donor specificities and 
trypanosomes do not follow many of the 
canonical rules developed for other eukaryotic 
N-glycosylation pathways, raising questions as
to the basic architecture and detailed function
of trypanosome OSTs.  Here, we show by blue-
native gel electrophoresis and stable isotope
labelling in cell culture proteomics that the
TbSTT3A and TbSTT3B proteins associate
with each other in large complexes that contain
no other detectable protein subunits. We
probed the peptide acceptor specificities of the
OSTs in vivo using a transgenic glycoprotein
reporter system and performed
glycoproteomics on endogenous parasite
glycoproteins using sequential endoglycosidase-
H and peptide-N-glycosidase-F digestions. This
allowed us to assess the relative occupancies of
numerous N-glycosylation sites by
endoglycosidase-H resistant N-glycans
originating from Man5GlcNAc2-PP-dolichol
transferred by TbSTT3A, and endoglycosidase-
H sensitive N-glycans originating from
Man9GlcNAc2-PP-dolichol transferred by
TbSTT3B. Using machine learning we assessed
the features that best define TbSTT3A and
TbSTT3B substrates in vivo and built an
algorithm to predict the types of N-glycan most 
likely to predominate at all the putative N-
glycosylation sites in the parasite proteome. 
Lastly, molecular modelling was used to suggest 
why TbSTT3A has a distinct preference for 
sequons containing and/or flanked by acidic 
amino acid residues. Together, these studies 
provide insights into how a highly divergent 
eukaryote has re-wired protein N-glycosylation 
to provide protein sequence-specific N-glycan 
modifications. Data are available via 
ProteomeXchange with identifiers PXD007236, 
PXD007267 and PXD007268. 
INTRODUCTION 
The tsetse-fly transmitted protozoan parasite 
Trypanosoma brucei and its close relatives are 
responsible for human and animal African 
trypanosomiasis. The animal-infecting 
bloodstream forms of these organisms depend on 
surface coats made of 
glycosylphosphatidylinositol (GPI) anchored and 
N-glycosylated variant surface glycoprotein
(VSG) to evade the innate host immune system (1)
and the acquired immune system through antigenic
variation (2). Further, they express many less
abundant glycoproteins such as their novel
transferrin receptors (3-5), a novel
lysosomal/endosomal protein called p67 (6), the
so-called invariant surface glycoproteins (ISGs)
(7) and invariant endoplasmic reticulum
glycoproteins (IGPs) (8), the Golgi/lysosmal
glycoprotein tGLP-1 (9), the membrane-bound
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histidine acid phosphatase TbMBAP1 (10), the 
flagellar adhesion zone glycoproteins Fla1 and 
Fla2 (11) and others. While some of these are 
bloodstream form specific glycoproteins (VSGs, 
ISGs, TbMAP1, transferrin receptors), others are 
common to the tsetse midgut-dwelling procyclic 
form of the parasite. Further, procyclic form 
parasites also express unique glycoproteins, 
notably the abundant GPI-anchored procyclins 
some of which are N-glycosylated (12,13) , and the 
partially characterised high-molecular weight 
glycoconjugate (14,15). Many of the N-glycan 
structures expressed by T. brucei have been solved 
and these include conventional oligomannose and 
biantennary complex structures as well as 
paucimannose and extremely unusual ‘giant’ poly-
N-acetyl-lactosamine (poly-LacNAc) containing
complex structures in the bloodstream form of the
parasite (16-19) . In contrast, only oligomannose
N-glycans have been structurally described in wild
type procyclic trypanosomes(12,20).
The unusual repertoire of T. brucei bloodstream 
form N-glycans and the original observation by 
Bangs and colleagues that EndoH-resistant N-
glycans appear immediately following protein 
synthesis (21) and not following transport to the 
Golgi apparatus, has stimulated our group to study 
the fundamentals of protein N-glycosylation in this 
divergent eukaryotic pathogen.  
Protein N-glycosylation is believed to be a 
ubiquitous post-translational modification among 
the eukaryotes, with the canonical model based 
primarily on extensive studies in mammalian cells 
and the yeast Saccharomyces cerevisiae, reviewed 
in (22,23). In this canonical model, there are a 
number of tenets that include: (i) The mature lipid-
linked oligosaccharide (LLO) donor and preferred 
substrate for oligosaccharyltransferases (OSTs) is 
Glc3Man9GlcNA2-PP-dolichol. (ii) The OSTs are 
hetero-oligomers of 8 or 9 distinct subunits. (iii) 
The OSTs may fall into two classes (A and B) 
according to their subunit composition with 
different peptide acceptor specificities. (iv) The 
ER enzyme UDP-glucose: glycoprotein  
glucosyltransferase (UGGT) operates on tri-
antennary Man9-7GlcNA2 structures with a 
complete a-branch, but not on bi-antennary 
structures. (v) The action of Golgi mannosidase II 
is a pre-requisite for the conversion of 
oligomannose to complex N-glycans. (vi) The 
enzymes GnTI and GnTII have strict acceptor 
substrate specificities, operating on Man5GlcNA2 
and GlcNAcMan3GlcNA2, respectively. However, 
none of these tenets apply to N-glycosylation in the 
protozoan parasite Trypanosoma brucei where: (i) 
The largest LLO is Man9GlcNA2 (24,25) and 
where different OSTs preferentially transfer either 
this structure or bi-antennary Man5GlcNA2 (25-
28) (ii) There is no evidence for OST subunits
other than the catalytic SST3 subunits in T. brucei
or the related parasites Trypanosoma cruzi and the
Leishmania (26,28-32). (iii) OST sub-classes and
their peptide acceptor specificities (which are
more disparate in T. brucei than for other
eukaryotes) are defined only by their STT3
components (28). (iv) The parasite UGGT works
efficiently on all structures (bi- and tri-antennary)
with an intact A-branch (33). (v) Golgi-
mannosidase II is absent, preventing the
conversion form the oligomannose series to the
complex series of N-glycans (25). (vi) The parasite
GnTI and GnTII GlcNAc-transferases have
different specificities to canonical GnTIs and
GnTIIs and belong to a different GT family
(34,35).
Here, we: (i) Directly address the oligomeric states 
of T. brucei STT3 subunits. (ii) Look for evidence 
for any non-canonical OST subunits in addition to 
the TbSTT3s. (iii) Probe the peptide acceptor 
specificities of TbSTT3A (Tb927.5.890) and 
TbSTT3B (Tb927.5.900) using a reporter 
glycoprotein expression system and by 
glycoproteomics. (iv) Use machine learning to 
predict which putative N-glycosylation sites in 
bloodstream form T. brucei will be modified by 
TbSTT3A or TbSTT3A. 
RESULTS 
Blue native gel electrophoresis of in situ tagged 
TbSTT3A suggests it is present in high 
molecular weight complexes. To enable 
immunoprecipitation of TbSTT3A, the 3’-end of 
the endogenous gene in a heterozygote cell line 
(TbSTT3A/B/C+/-) was in situ tagged with a 
sequence encoding a C-terminal HA3 epitope. 
Transfected cells were cloned and analysed by 
Southern blotting to confirm correct insertion of 
the tag (Figure S1A). To check that the tag did not 
impair the function of TbSTT3A, the glycosylation 
of VSG221 was analysed in these cells. VSG221 
receives different types of glycan at the two N-
glycosylation sequons in the protein; EndoH-
resistant Man5GlcNAc2 at N263 and EndoH-
sensitive Man9GlcNAc2 at N428 (17,28). 
Following PNGaseF and EndoH treatment the 
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 3 
typical digestion pattern for wild-type VSG221 
was seen also for the transgenic cells (Figure S1B), 
showing that C-terminally tagged TbSTT3A-HA3 
is functional. Subsequently, cells were lysed under 
mild conditions (0.5% digitonin on ice for 30 min) 
and the clarified cell lysates were incubated with 
anti-HA mouse antibody, followed by magnetic 
beads coupled to protein G. The pull-out eluates 
were analysed by SDS-PAGE and Western 
blotting using an anti-HA antibody. As expected, 
epitope tagged TbSTT3A-HA3 was detected 
running just below the position of the 75 kDa 
molecular weight marker in the TbSTT3A-HA3 
pull-out, whereas no band was seen in the wild-
type cell pull-out (Figure 1A). However, when 
same eluates were analysed by blue native gel 
electrophoresis and anti-HA Western blotting, a 
smear (specific for the TbSTT3A-HA3 cell line) 
was detected between 700 and 1200 kDa, 
suggesting that TbSTT3A is present in large 
complexes (Figure 1B). 
 
SILAC proteomics shows TbSTT3A and 
TbSTT3B form hetero-oligomeric complexes 
without other subunits. Since the results from the 
blue native gel electrophoresis suggested 
TbSTT3A is present in high molecular weight 
complexes, we carried out pull-out experiments 
using stable isotope labelling in cell culture 
(SILAC). For this experiment, wild-type and 
transgenic parasites (expressing TbSTT3A-HA3) 
were grown under identical conditions for eight 
cell divisions, except that the transgenic 
TbSTT3A-HA3 cell line was grown in “heavy 
medium” containing stable isotope-labelled Lys 
and Arg (R6K4), whereas the wild-type cells were 
grown in “light medium” containing unlabelled 
Lys and Arg (R0K0). The transgenic TbSTT3A-
HA3 and the wild-type cells were harvested, 
washed, counted, mixed together in a 1:1 ratio and 
lysed in 0.5 % digitonin buffer. Anti-HA 
antibodies and protein G magnetic beads were 
used to pull-out the TbSTT3A-HA3 tagged protein, 
and any binding partners, and the bead eluate was 
processed to tryptic peptides for LC-MS/MS 
analysis. In this kind of SILAC experiment, 
TbSTT3A-HA3 and any proteins specifically 
associated with it can be distinguished from 
nonspecific contaminant proteins by the isotope 
ratios of their tryptic peptides. Thus, TbSTT3A-
HA3 and true associated protein peptides will have 
high heavy/light isotope ratios, whereas 
contaminant proteins will have approximately 
equal heavy/light isotope ratios (Figure 2A). The 
data set from the experiment was used to search a 
T. brucei predicted protein database using 
MaxQuant software. Each protein was displayed 
on a plot of the Log10 value of the intensities of the 
unique peptides of that protein (y axis) and the 
Log2 value of the heavy to light isotope ratios of 
the same peptides (x axis) (Figure 2B). The 
TbSTT3A-HA3 (bait) protein had the highest 
heavy/light ratio (14 : 1), closely followed by 
TbSTT3B (10 : 1). Only three other proteins were 
significantly enriched (orange crosses, Figure 2B). 
However, these were only marginally (1.5-fold) 
enriched hits that are not known to localise to the 
ER.  
 
The TbSTT3A-HA3 cell line was further modified 
by the in-situ tagging of the remaining TbSTT3B 
allele, to yield a cell line expressing C-terminally 
MYC3-tagged TbSTT3B-MYC3. A 
complementary SILAC experiment, using in situ 
TbSTT3B-MYC3 tagged bait and an anti-MYC 
pull-out, produced similar result to the TbSTT3A-
HA3 pull-out, with TbSTT3A being the only 
obvious binding partner for TbSTT3B-MYC3 
(Figure 2C). In this case, there was one other 
significant protein hit (orange cross, Figure 2C), 
corresponding to a glucose transporter, but this 
was different from those seen in (Figure 2B) and 
also unlikely to be an ER component.  
 
Taken together, these data suggest that TbSTT3A 
and TbSTT3A form hetero-oligomeric complexes, 
with no other candidate subunits, although we 
cannot rule out the presence of low-affinity 
subunits that might be lost during 
immunoprecipitation.  
 
The data for the SILAC proteomics experiments 
can be found at ProteomeXchange under entry 
PXD007236.  
 
Co-immunoprecipitation of TbSTT3A-HA3 and 
TbSTT3B-MYC3. The result from the SILAC 
pull-out experiments suggested that TbSTT3A is 
in a complex with TbSTT3B and to further test this 
hypothesis immunoprecipitation (IP) experiments 
were performed. Cells from the double-tagged cell 
line were harvested, washed and lysed in 0.5 % 
digitonin and TbSTT3A-HA3 or TbSTT3B-MYC3 
was captured from the lysate using anti-HA or 
anti-MYC magnetic beads. Subsequently, the 
tagged proteins were detected by Western blotting 
using anti-HA and anti-MYC antibodies. Wild 
type cell lysates (containing no HA or MYC 
tagged genes) were used as a control. The results 
from the co-IP experiments are shown in (Figure 
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 4 
3). As expected, no bands in the region of 
TbSTT3A-HA3 or TbSTT3B-MYC3 were seen in 
the IPs from the control wild-type lysates (Figure 
3, lanes 1, 3, 5 and 7). Also, as expected, 
TbSTT3A-HA3 and TbSTT3B-MYC3 were 
detected in the homologous anti-HA IP / anti-HA 
blot (Figure 3, lane 2) and anti-MYC IP / anti-
MYC blot (Figure 3, lane 8). Significantly, 
TbSTT3B-MYC3 can be seen to co-IP with 
TbSTT3A-HA3 (Figure 3, lane 6) and TbSTT3A-
HA3 can be seen to co-IP with TbSTT3B-MYC3 
(Figure 3, lane 4), confirming their physical 
association predicted by the SILAC experiment.  
 
In these experiments, the anti-HA IP / anti-HA 
Western blot signal for TbSTT3A-HA3 is much 
stronger than the anti-MYC IP / anti-MYC 
Western blot signal for TbSTT3B-MYC3. While 
some of this difference may be due to relative 
antibody affinities, it is also consistent with the 
higher expression of TbSTT3A in wild-type 
bloodstream form trypanosomes at both the 
mRNA and protein levels (28,36). The co-IP data 
suggest that a significant proportion of the total 
TbSTT3B-MYC3 appears in the TbSTT3A-HA3 IP 
(Figure 3, compare lanes 6 and 8), whereas only a 
minority of TbSTT3A-HA3 appears in the 
TbSTT3B-MYC3 IP (Figure 3, compare lanes 2 
and 4). These data suggest that there may be some 
high molecular weight complexes made 
exclusively, or almost exclusively, of TbSTT3A 
whereas all, or most, of the TbSTT3B is present in 
complexes containing TbSTT3A.  
 
Probing peptide acceptor substrate specificities 
of TbSTT3A and TbSTT3A using a reporter 
glycoprotein expression system. TbSTT3A is 
responsible for co-translational transfer of 
biantennary Man5GlcNAc2 predominantly to N-
glycosylation sequons containing and/or flanked 
by acidic amino acids, whereas TbSTT3B 
catalyses post translational transfer of triantennary 
Man9GlcNAc2 to the remaining sterically 
accessible sequons (28). To improve our 
understanding of the acceptor peptide specificity 
in T. brucei, an in vivo assay was established using 
an artificial reporter glycoprotein, based on the 
TbBiPN system described in (37). TbBiPN is a 
non-glycosylated truncated version of TbBiP, 
retaining its N-terminal signal peptide but lacking 
its C-terminal ER retention peptide, which enters 
the ER and is eventually secreted out of the cell via 
the Golgi apparatus. A pLEW82 expression 
plasmid (38) was modified to contain the TbBiPN 
open reading frame fused to a 3’-sequence into 
which we could insert additional sequences, via 
AvrII and MfeI restriction sites, immediately 
upstream of a C-terminal HA3 epitope tag. This 
construct was used to introduce sequences 
encoding a single reporter N-glycosylation sequon, 
flanked by five amino acid residues on each side. 
These TbBiPN-[XXXXXNXTXXXXX]-HA3 
constructs were transformed into bloodstream 
form trypanosomes to express the reporter 
glycoprotein.   
We first validated the in vivo reporter assay by 
introducing TEGLLNATDEIAL and 
TILKSNYTAEPVR into the TbBiPN construct 
and expressing them in T. brucei. The former 
sequence (with a pI of 3.42) is found in VSG 
MITat1.8 and is known, in that context, to receive 
exclusively biantennary Man5GlcNAc2 from 
TbSTT3A (39), whereas the latter (with a pI of 8.3) 
is found in the ESAG6 subunit of the transferrin 
receptor and is known not to be recognised and 
modified by TbSTT3A and, therefore, receives 
exclusively triantennary Man9GlcNAc2 from 
TbSTT3B (5). Aliquots of trypanosome lysates 
expressing these constructs were treated with and 
without EndoH or PNGaseF, followed by SDS-
PAGE gel and Western blotting with anti-HA 
antibodies. The endoglycosidase EndoH can only 
digest triantannary Man9GlcNAc2 glycans 
transferred by TbSTT3B, whereas PNGaseF can 
digest both Man9GlcNAc2 and biantennary 
Man5GlcNAc2 transferred by TbSTT3A. Thus, 
distinct digestion patterns, depending on what 
type(s) of glycan(s) are bound to the sequon 
asparagine, can be visualised by Western blotting. 
The in vivo reporter assay faithfully recapitulated 
the experimental data for the VSG MITat1.8 and 
ESAG6 glycosylation sites, with 
TEGLLNATDEIAL- and TILKSNYTAEPVR-
containing TbBipN glycoproteins occupied 
predominantly by EndoH-resistant and EndoH-
sensitive glycans, respectively (Figure S2).  
 
Next, we investigated how each position flanking 
and within the sequon affects TbSTT3A 
recognition and transfer. First, the neutral 
sequence AAAAANATAAAAA (pI 6.01) was 
introduced into the reporter glycoprotein. For this 
construct, the majority (about 93% as measured by 
quantitative Licor imaging of the upper and lower 
bands of the EndoH-digests) of the anti-HA 
binding signal was sensitive to EndoH (Figure 4A, 
lane 1; Table 1). One aspartic acid was then 
introduced in all eleven possible positions, 
yielding peptides with the same pI value (3.10), 
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 5 
and the proportion of the reporter glycoprotein 
processed by TbSTT3A (and therefore resistant to 
EndoH) was measured (Figure 4A, lanes 2 and 3; 
Table 1). The quantitative data, derived from two 
technical replicates of three biological replicates 
(Table 1), are summarised in (Figure 4B). From 
these data, it can be seen that the aspartic acid scan 
across the different positions leads to variation in 
recognition and glycan transfer by TbSTT3A; with 
the two positions immediately flanking the Asn 
residue apparently having the greatest influence 
and with residues N-terminal to the glycosylation 
sequon having greater influence to those C-
terminal to the sequon.  
Probing endogenous peptide acceptor substrate 
specificities of TbSTT3A and TbSTT3B by 
glycoproteomics. The glycoproteomics data from 
(28) were reprocessed and significantly 
augmented by combing them with data derived 
from the experiments outlined in Experimental 
Procedures. These experiments assess whether the 
endogenous trypanosome N-glycosylation sites 
are occupied by EndoH-sensitive oligomannose 
glycans (originating from the action of TbSTT3B) 
or by EndoH-resistant paucimannose and/or 
complex glycans (originating from the action of 
TbSTT3A).  
Parasites were osmotically lysed to release ˃90% 
of the VSG coat as soluble form VSG (sVSG), 
through the action of the endogenous GPI-specific 
phospholipase C (40,41). The recovered cell 
ghosts, containing majority of the non-VSG 
cellular glycoproteins, were solubilized, denatured 
and S-alkylated. This preparation was then 
processed in two ways. In one approach the intact 
glycoproteins were first affinity purified using 
immobilized ricin (RCA120) and Concanavalin-A 
(ConA) lectins. The enriched glycoproteins were 
then sequentially digested with EndoH and 
PNGaseF (the latter in the presence of H2[18O]), 
and digested with Lys-C and trypsin. In the other 
approach the denatured and S-alkylated proteins 
were first digested with Lys-C and trypsin and the 
glycopeptides were trapped with ricin (RCA120) 
and ConA and subsequently digested with EndoH 
and PNGaseF (the latter in the presence of 
H2[18O]). In both cases, the resulting peptides were 
analysed by LC-MS/MS and the data used to 
search the T. brucei predicted protein database 
allowing for the possible presence of Asn-N-
GlcNAc residues, the product of EndoH cleavage, 
and/or for the conversion of Asn residues into 
[18O]Asp residues, the product of PNGaseF 
cleavage. These data, and reprocessed data from 
Izquierdo et al. (28), are shown in (Supplementary 
Table S1). Peptides containing Asn-N-GlcNAc 
and/or [18O]Asp within an Asn-X-Ser/Thr sequon 
that were detected >=3 times were assigned as 
being predominantly TbSTT3A or TbSTT3B 
substrates when the proportion of the [18O]Asp 
feature was >= 0.8 and <=0.4, respectively 
(Supplementary Table S2). We then analysed the 
amino acid frequencies immediately adjacent to N-
glycosylation sequons of the assigned TbTT3A 
and TbTT3B substrates using WebLogo (42). The 
enrichment of negatively charged residues is the 
most striking feature of the TbSTT3A substrates 
(Figure 5A) along with a bias towards Thr over Ser 
in the sequon +2 position. Conversely, the 
TbSTT3B substrates are relatively enriched for 
positively charged residues upstream of the sequon 
but show no preference for Thr over Ser in the +2 
position (Figure 5B). The data were also analysed 
by the two-sample logo visualization method (43), 
which compares two input peptide sequence lists 
against each other, highlighting features that 
predominate in each. This suggests enrichment for 
negatively charged amino acids, especially at 
positions -6, - 3, +6 and +7 for the TbSTT3A 
substrates and a preference for hydrophobic and 
positively charge amino acids in the -1 to -5 
positions of the TbSTT3B substrates (Figure 5C). 
The reprocessed data of (19) can be found at 
ProteomeXchange under entry PXD007237 and 
the new glycoproteomics data under PXD007238.  
 
Building a glycosylation site predictor for T. 
brucei using machine learning. Machine 
learning has been successfully used in biological 
research to infer the peptide recognition 
specificities of, for example, protein kinases, 
phosphatases and SH2 domains (44). The first 
step of machine learning consists in transforming 
peptide sequences into biochemical features 
such as charge, hydrophobicity and relative 
positions. These features, organized in a 
machine-readable template, are than evaluated 
by artificial intelligence algorithms to highlight 
which amino acid properties of a peptide 
sequences are the most important in determining 
substrate recognition. We therefore decided to 
apply a machine learning approach to further 
leverage our glycoproteomics and glycoprotein 
reporter data and build an ensemble of prediction 
algorithms to assign putative N-glycosylation 
sites in the predicted T. brucei proteome. This 
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 6 
ensemble algorithm (Voting Classifier) averages 
the outputs of a Random Forest classifier (RF), 
an Extra Tree Classifier (ETC) and a Support 
Vector Machine (SVM) classifier to predict 
which putative N-glycosylation sites will more 
likely be modified by TbSTT3A or TbSTT3B.  
The RF, ETC and SVM classifiers all weigh the 
features derived from the upstream (amino-
terminal) side of the glycosylation sequon more 
than the features extracted from the downstream 
(carboxy-terminal) side (Supplementary Figure 
S3A-C). Moreover, the RF, ETC and SVM 
classifiers all preferentially use the cumulative 
negative charge upstream of the glycosylated 
asparagine, and the hydrophobicity of the 
peptide upstream and downstream, to 
discriminate between TbSTT3A and TbSTT3B 
substrates (Figure S4).  We could detect a core 
of 5 important features shared by the three 
classifiers, namely the charge at pH 7.3 and the 
isoelectric point for the sequon ± 10 amino acid 
residues, the cumulative charge upstream the 
modified asparagine with a window of 13 and 16 
amino acids and the bonus score derived from 
the aspartic acid scanning experiment described 
in (Figure 4), see Experimental Procedures. A 
list of putative N-glycosylation sites and the 
Voting Classifier predictions are shown in 
(Supplementary Table S3). We performed a two-
sample logo visualization on the output (Figure 
5D). As expected, the trends in plot are similar 
to those generated from the glycoproteomics 
data alone (Figure 5C).  
Molecular modelling. Although TbSTT3C 
(Tb927.5.910) has not been studied in this paper 
because it is not expressed at detectable levels in 
bloodstream form T. brucei, data from its 
heterologous expression in yeast suggests that its 
peptide acceptor specificity is much more similar 
to TbSTT3A than TbSTT3B (28,45). To try to 
rationalise the preferences of TbSTT3A and 
TbSTT3C for acceptor sequons containing and/or 
flanked by negatively charged amino acid 
residues, we built molecular models of TbSTT3A, 
TbSTT3B and TbSTT3C using Phyre2 (46) based 
on the Campylobacter lari PglB structure (47). 
The predicted models were aligned with the PglB 
structure using PDBeFold (48) and the binding 
pockets of TbSTT3A and TbSTT3B were 
visualized with Chimera (49). Next, we looked for 
basic amino acid residues that were conserved in 
TbSTT3A and TbSTT3C that were different in 
TbSTT3B (Figure S6). Of these, the active site 
proximal residue 397 is particularly interesting as 
it contains a His residue in TbSTT3B but an Arg 
residue in TbSTT3A and TbSTT3C. Arginine has 
a flexible and strongly basic guanidinium cation 
side chain that could conceivably interact with 
acidic amino acid residues at or close to the NXS/T 
glycosylation sequon in the active site. Position 
406 contains an Arg residue in TbSTT3A and 
TbSTT3C (in place of a neutral Gly residues in 
TbSTT3B) that could also conceivably interact 
with sequon-adjacent anionic residues in the 
acceptor peptide. Such ionic interactions between 
the acceptor peptide and the enzyme surface might 
increase the efficiency of substrate recognition and 
glycosylation of sequons containing and/or 
flanked by acidic amino acids.  
 
DISCUSSION 
Although the T. brucei genome does not encode 
for any indentifiable OST subunits, other than 
three intact and one truncated TbSTT3, we decided 
to investigate whether there might be novel non-
canonical T. brucei OST subunits. Precedents for 
kinetoplastid-specific subunits of otherwise 
conserved cellular machineries include clathrin-
associating proteins and endocytic components 
(50,51), exocyst components (52), nuclear pore 
complex and nuclear lamina components (53,54) 
and subunits of the GPI transamidase (55). Blue-
native gel electrophoresis of gently solubilised 
epitope-tagged endogenous TbSTT3A showed 
that it is present in high-molecular weight 
complexes, but quantitative SILAC proteomics of 
tagged TbSTT3A and TbSTT3B pull-outs showed 
that while these are mutual binding partners 
(confirmed by co-immunoprecipitation), no other 
subunits could be found by these methods. The 
lack of non-canonical or canonical T. brucei OST 
subunits (other than the STT3 catalytic subunits) 
is consistent with the ease with which T. brucei 
and other kinetoplastid STT3s can be functionally 
expressed in other eukaryotes, like S. cerevisiae 
and Pichia pastoris (29,31,32,56). Nevertheless, 
the blue-native gel and co-immunoprecipitation 
experiments show that, at least in the native 
environment of a bloodstream form trypanosome, 
TbSTT3A associates with itself and with the less-
abundant TbSTT3B to form complexes with 
apparent molecular weights of between 600 kDa 
and 1.2 MDa. The nature of these complexes 
remains to be determined but has implications for 
how and whether TbSTT3s associate with the 
parasite translocon complex and how they access 
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nascent glycoprotein sequons during and/or 
following protein translocation. The 
dimer/oligomer nature of yeast OST subunits, 
including Stt3, has been previously described (57). 
To probe TbSTT3 peptide acceptor substrate 
specificities, we developed an artificial 
glycoprotein reporter system, based on a truncated 
version of TbBiP (37) fused to a single 
glycosylation sequon flanked by five variable 
residues on either side. Constructs were expressed 
in bloodstream form T. brucei and their products 
assayed for the relative proportions of N-
glycosylation by TbSTT3A and TbSTT3B. With 
this we able to recapitulate the preferential N-
glycosylations of native peptide acceptor 
sequences. We then applied the system to analyse 
the N-glycosylation of an artificial 13-mer 
sequence (AAAAANATAAAAA) into which we 
sequentially introduced a single D residue in all 11 
possible A sites. The data clearly confirmed that 
the presence of an acidic amino acid proximal to 
the sequon significantly increased its N-
glycosylation by TbSTT3A, with the -1 and +1 
positions relative to the N-glycosylated Asn 
residue having the greatest effect and the positions 
N-terminal to the sequon having a greater effect 
than those C-terminal to the sequon.  
 
We then created a richer glycoproteomics dataset 
than we previously reported (28) by combining 
two alternative approaches: (i) Glycoprotein 
enrichment by lectin affinity chromatography, 
followed by trypsin digestion and sequential 
EndoH and PNGaseF digestion and (ii) Tryptic 
glycopeptide enrichment by lectin affinity 
chromatography, followed by trypsin digestion 
and sequential EndoH and PNGaseF digestion. In 
both cases, the PNGaseF digestion step was 
performed in H2[18O] to distinguish between 
PNGaseF-mediated Asn deamidation and non-
enzymatic deamidation during sample preparation 
and handling. These data were combined with 
reprocessed raw data from (28) to provide 
quantitative data on TbSTT3A and TbSTT3B N-
glycosylation of 141 unique N-glycosylation sites. 
Logo plots confirmed the enrichment of acidic 
amino acid residues (Asp and Glu) surrounding 
TbSTT3A N-glycosylated sequons, the general 
depletion of hydrophobic residues and the 
selective depletion of basic residues (Arg and Lys) 
N-terminal to the sequon.  
 
We also used hypothesis-free machine learning 
techniques to identify features that predispose 
sequons to be preferentially modified by 
TbSTT3A or TbSTT3B and, finally, combined 
these features and parameters derived from the 
experimental reporter glycoprotein data to develop 
a Voting Classifier prediction algorithm. This 
predictor was then applied to all the putative N-
glycosylation sequons in the T. brucei proteome to 
predict those sites preferentially modified by 
TbSTT3A (leading to paucimannose and/or 
complex N-glycan occupancy) or TbSTT3B 
(leading to oligomannose N-glycan occupancy) in 
bloodstream form trypanosomes. Two-sample 
logo plot analysis of the output (a total of 1,291 
predicted occupied N-glycosylation sites) largely 
echoes the experimental glycoproteomic and 
reporter glycoprotein data and implies that the 
TbSTT3A N-glycosylation sites are enriched for 
acidic residues and depleted of basic and 
hydrophobic residues, with the effects of these 
features more profound to the N-terminal side and 
within the sequon than to the C-terminal side of the 
sequon.  
 
It is important to note that available pulse-chase 
data (21,58) suggest that TbSTT3A modifies VSG 
glycoproteins co-translationally, whereas 
TbSTT3B can act post-translationally (25) and that 
TbSTT3A and TbSTT3B knockdown data suggest 
that TbSTT3B is able to modify TbSTT3A sites, 
but not vice versa (28). Thus, all or most the 
aforementioned TbSTT3A versus TbSTT3B 
sequon selectivity features are dictated by the 
peptide/sequon acceptor specificity of TbSTT3A 
and not TbSTT3B, which appears to be able to 
utilise sequons in almost any amino acid sequence 
context. This property of TbSTT3B could be 
particularly useful from a biotechnological point 
of view to boost the efficient N-glycosylation of 
recombinant glycoproteins in eukaryotic 
expression systems. It also nicely explains why 
trypanosomes can transition from expressing a rich 
mixture of oligomannose and 
paucimannose/complex N-glycans in the 
bloodstream form parasite (16,18,19)  to 
predominantly oligomannose N-glycans in the 
procyclic form of the parasite (12,20) by simply 
down-regulating the expression of TbSTT3A, as 
observed at both the mRNA (28,59) and protein-
levels (36,60,61).  
 
The results reported here and in (45) are consistent 
with the mechanisms of resistance in T. brucei to 
certain toxic lectins and carbohydrate-binding 
small molecules reported in an interesting series of 
studies (62-64). These workers demonstrated that 
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 8 
the parasites could escape the effects of these 
trypanocidal agents, all of which bind principally 
to oligomannose N-glycans, by either switching to 
the expression of a VSG type that naturally does 
not carry oligomannose N-glycans or by 
supressing the expression of TbSTT3B. In this 
way, the parasites effectively exchange 
oligomannose for puacimannose and complex N-
glycans that are poor ligands for the trypanocides.  
 
Interestingly, TbSTT3A and TbSTT3B are found 
in tandem array in the trypanosome genome, 
together with a preceding truncated TbSTT3 
pseudogene and followed by a full-length 
TbSTT3C gene that is more similar to TbSTT3B 
than to TbSTT3A. However, TbSTT3C is not 
significantly expressed in bloodstream form or 
procyclic form of the parasite (28,36,59-61). 
Nevertheless, transgenic expression of TbSTT3C 
in S. cerevisiae clearly shows that it is a functional 
OST with a similar preference for sequons flanked 
by acidic amino acids to TbSTT3A but an LLO 
donor specificity like TbSTT3B (28) and 
(45).Amino acid sequence alignment of 
TbSTT3A, B and C and molecular modelling 
building, based on the Campylobacter lari PglB 
structure (47) was performed. The models suggest 
that the presence of a large, flexible and highly 
positively charged Arg residue sidechain (R397) 
very close to the active site of the enzyme in 
TbSTT3A and TbSTT3C, compared to a His 
residue in TbSTT3B, may play a role in the 
selectivity of TbSTT3A and TbSTT3C for sequons 
containing and flanked by acidic Asp and Glu 
residues. TbSTT3A and TbSTT3C also contain 
Arg residues in place of neutral Q567 and G406 
residues in TbSTT3B, locations close enough to 
the active site to potentially interact with sequon-
flanking anionic residues. The accompanying 
paper (45)  elegantly addresses the issues of 
peptide acceptor and LLO donor specificities of all 
three TbSTT3s by heterologous expression of each 
and chimeras thereof in various yeast mutants. 
That paper concludes that the region containing 
R397 and R406 in TbSTT3A and TbSTT3C 
controls peptide acceptor specificity, and this is 
consistent with our suggestions from molecular 
modelling.  
 
There are similarities and differences between the 
multi-subunit mammalian STT3A- and STT3B-
based OSTs and the single subunit TbSTT3A and 
TbSTT3B OSTs of T. brucei: (i) In both, the 
STT3A OSTs operate co-translationally and get 
the first option to glycosylate a given sequon, 
whereas the STT3B OSTs can operate post-
translationally on what is left (25,65).  (ii) In both, 
the OSTs show differences in peptide acceptor 
substrate specificity. However, in T. brucei this is 
controlled by the physicochemical properties of 
the amino acids surrounding the acceptor sequon, 
whereas in mammalian cells this is controlled by 
the position of the sequon relative to the C-
terminus of the protein (66) or proximity to the 
signal-peptide cleaved N-terminus of the protein 
and to cysteine residues (67-69). The latter appears 
to relate to the presence of the mutually redundant 
MagT1 or TUSC3 thioredoxin-like 
oxidoreductase subunits (equivalent to the yeast 
Ost3 and Ost6 subunits) in the STT3B OST that 
may form mixed disulphides with the sequon 
proximal cysteine residues and thus increase 
residence time with the STT3B OST (69,70). A 
role for oxidoreductase activities of Ost3 and Ost6 
in yeast OST acceptor site specificity was also 
previously (71,72). In this regard, it is worth 
noting that TbSTT3B and TbSTT3C contain a 
CXC motif (absent in TbSTT3A) that are predicted 
from the C. lari OST structure to be proximal to 
the acceptor peptide (47). Such CXC sequences 
can have a disulphide isomerase activity (73) that 
might conceivably increase the acceptor substrate 
range of TbSTT3B and TbSTT3C. (iii) Whereas 
both STT3A and STT3B OSTs prefer the mature 
Glc3Man9GlcNAc2-PP-dolichol LLO donor, the T. 
brucei OSTs have distinct LLO donor specificities 
such that the presence of the ALG12-dependent c-
branch of the conventional (but glucose-free) 
triantennary Man9GlcNAc2-PP-dolichol LLO is 
required by TbSTT3B but not tolerated by 
TbSTT3A (27) and (45). An important 
consequence of this differential LLO specificity is 
that, because Golgi mannosidase II activity is also 
absent in T. brucei, N-glycans derived from 
TbSTT3B glycosylation cannot be processed to 
paucimannose or complex structures, which must 
instead be derived exclusively from TbSTT3A 
glycosylation.  
 
In summary, the two simultaneously operating 
acceptor substrate- and donor substrate-specific N-
glycosylation systems of bloodstream form T. 
brucei have been further characterized in this 
paper. While no canonical OST subunits, other 
than catalytic STT3 subunits, could be found the 
parasite genome, we can now confirm that there 
are no non-canonical subunits either. Instead, 
TbSTT3A and TbSTT3B appear form multimeric 
high-molecular weight complexes containing 
either TbSTT3A alone or TbSTT3A and 
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TbSTT3B. Further insights into the peptide 
acceptor specificity of TbSTT3A have been 
provided and an algorithm has been generated to 
predict, proteome-wide, which OST will likely 
operate on which putative N-glycosylation site. 
Taken together with the unusual specificities of T. 
brucei UGGT, GnTI and GnTII enzymes 
described in the introduction (19,34,35), and the 
apparent absence of a regulated ER unfolded 
protein response (19,74), we may conclude that 
protein N-glycosylation and downstream 
processing in this divergent eukaryote is worthy of 
note, and that its unusual features may provide 
therapeutic possibilities.   
 
 
 
EXPERIMENTAL PROCEDURES 
Cultivation of Trypanosomes. Bloodstream form 
Trypanosoma brucei, genetically modified to 
express T7 polymerase and the tetracycline 
repressor protein (38), were cultured in HMI-9T 
medium (75) supplemented with 10 % fetal calf 
serum, 2 mM GlutamaxTM (Invitrogen) and 56 µM 
1-thioglycerol (in place of 2-mercaptoethanol) and 
2.5 µg/ml G418 antibiotic at 37 oC in a 5% CO2 
incubator. Other antibiotics used, as appropriate, 
were hygromycin (4 µg/ml), puromycin (2.5 
µg/ml), phleomycin (0.1 µg/ml) and tetracycline 
(0.5 µg/ml). SILAC labelling, using dialysed fetal 
calf serum, was performed in HMI11-SILAC 
media, as described in (36). L-Arginine U−13C6 
and L-Lysine 4,4,5,5-
2
H4 (R6K4) were purchased 
from Cambridge Isotope Labs.   
Generation of genetically modified 
trypanosomes with in situ tagged TbSTT3A-
HA3 and TbSTT3B-MYC3. The TbSTT3A,B,C-/+ 
heterozygote described in (28) was used for C-
terminal HA3 in-situ tagging of the remaining 
TbSTT3A allele using a pMOTagH4 plasmid and 
C-terminal MYC3 in-situ tagging of the remaining 
TbSTT3B allele using a pMOTag4M4 plasmid 
(76). For the pMOTagH4 plasmid, the 1328-bp 
from the C-terminus of TbSTT3A and the 1057-bp 
3’ UTR downstream of the gene orf were PCR-
amplified from genomic DNA using Kod Hot Start 
polymerase with primers 5’-
ataagtatctcgagcaagtttgcttgccccgttcg-3’ and 5’-
ataagtaactcgagctcgctctgaaaatacaggttttcgacttcgtaa
tggaaccgcttcgct-3’ and 5’-
ataagtatggatccccacatcgtttcaatcgccgc-3’ and 5’-
ataagtaaggatccactcacaatcgtgcttacagcc-3’ as 
forward and reverse primers, respectively. The 
PCR products were cloned into the plasmid using 
the XhoI and BamHI (underlined). A TEV 
restriction site was included downstream of the orf 
of TbSTT3A (italics). The construct was linearized 
before being transfected into the TbSTT3A,B,C-/+ 
heterozygote cell line and transfected cells were 
selected by addition of hygromycin. The 
pMOTag4M4 plasmid was ordered from 
Genescript. It included 1032-bp from the C-
terminus of TbSTT3B, located upstream of the 
MYC3 epitope in the plasmid. The plasmid also 
included 835-bp of the 3’ UTR of TbSTT3B which 
were located downstream of the blasticidin 
resistance gene in the plasmid. The construct was 
linearized before being transfected into the 
TbSTT3A,B,C-/+ ; TbSTT3A-HA3 heterozygote 
cell line and transfected cells were selected by 
addition of blasticidin. 
SDS-PAGE and Western blotting. Reducing 
SDS-PAGE was run using pre-cast Novex Bis-Tris 
gels with MOPS running buffer (Invitrogen). 
Proteins were transferred to nitrocellulose using an 
iBlot system (Invitrogen) and stained with 
Ponceau S (Sigma) before being blocked in 50 mM 
TrisHCl, 0.15 M NaCl, 0.05 % Tween 20, 0.25 % 
BSA, 0.05 % Na and 2 % fish skin gelatin pH 7.4 
for 20 min. The membrane was then incubated for 
30 min with primary antibody in a 50 ml Falcon 
tube followed by washing using a SnapID system 
(Millipore). Subsequently, the labelled secondary 
antibody was incubated for 30 min followed by a 
washing step. The blots were imaged using an 
ODYSSEY® SA near infrared imager (LI-COR 
Biosciences). Secondary LI-COR antibodies 
(IRDye-800CW goat anti-mouse 1:15000 or 
IRDye-680RD donkey anti mouse 1:20000) were 
used to bind the primary mouse anti-HA and anti-
MYC antibodies.  
 
Blue native gels and Western blotting. Blue 
Native gel electrophoresis was run using 
components from the Native Page kit (Invitrogen). 
The protocol was followed to the manufacturer’s 
instructions except that no G-250 was added to the 
sample buffer and the 1x NativePage Light 
Cathode buffer was diluted 1:4 in 1x running 
buffer to reduce Coomassie interference of the 
post-blotting LiCor imaging.  
 
Immunoprecipitation. Cells cultures (100 ml) 
were grown to log phase (approximately 2.5x106 
cells/ml) and lysed for 30 min on ice in 0.5% 
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digitonin, 50 mM Tris-HCl pH6.8, 20 mM EDTA 
plus the protease inhibitors 0.8 mM PMSF, 0.1 
mM TLCK, and 1 x EDTA-free protease inhibitor 
cocktail (Roche). Subsequently, the lysate was 
centrifuged (4°C, 11000g, 15 min) and the 
supernatant was moved to a new tube. Protein G 
magnetic beads, pre-washed in lysis buffer, were 
added to the lysate (30 min, 4°C) and captured to 
absorb nonspecific binding components. The 
lysate was moved to a new tube followed by 
incubation for 1 h with anti-HA or anti-MYC 
antibody (1 µg/ml) at 4°C followed by fresh pre-
washed magnetic beads. The beads were captured 
and washed twice with 1 ml of lysis buffer and 
once with 10 mM Tris-HCl pH6.8, 4 mM EDTA, 
0.1 % digitonin containing the same protease 
inhibitors. Proteins were eluted from the beads in 
30 µl reducing SDS-sample buffer with heating 
(100°C for 10 min). The eluted proteins where 
subsequently separated by SDS-PAGE.  
 
SILAC proteomics. Heavy and light labelled cells 
were harvested separately (15 min, 800 g, 4 °C) 
and washed and resuspended in trypanosome 
dilution buffer (20 mM Na2HPO4, 2 mM 
NaH2PO4, 80 mM NaCl, 5 mM KCl, 20 mM 
glucose) for cell counting. The cells were mixed 1 
: 1 before undergoing immunoprecipitation, as 
described above. The eluted proteins in 25 µl 
reducing SDS sample buffer were S-alkylated with 
5 µl 300 mM iodoacetamide (30 min, dark) and 
loaded on Novex NUPAGE 4-12% Bis Tris gel 
and run at 200 V using MOPS buffer until the 
proteins had migrated about 2 cm into the gel 
(visualised by Simply Blue Safe Stain, Thermo 
Fisher). The protein-containing region of the gel 
was excised and subjected to in-gel trypsin 
digestion and aliquots of the extracted peptides 
were analysed on an LTQ-Orbitrap Velos Pro 
mass spectrometer coupled with a Dionex 
Ultimate 3000 RS HPLC system (Thermo Fisher). 
The sample peptides were loaded at 5 μL/min onto 
a trap column (100 μm × 2 cm, PepMap nanoViper 
C18 column, 5 μm, 100 Å, Thermo Scientific) 
equilibrated in 98% buffer A (2% acetonitrile and 
0.1% formic acid (v/v)) and 2% buffer B (80% 
acetonitrile and 0.08% formic acid (v/v)). The trap 
column was washed for 3 min at the same flow rate 
and then switched in-line with a Thermo Scientific 
resolving C18 column (75 μm × 50 cm, PepMap 
RSLC C18 column, 2 μm, 100 Å). The peptides 
were eluted from the column at a constant flow rate 
of 300 nl/min with a linear gradient from 98% 
buffer A to 40% buffer B in 128 min, and then to 
98% buffer B by 130 min. LTQ-Orbitap Velos Pro 
was used in data dependent mode. A scan cycle 
comprised an MS1 scan (m/z range from 335-
1800) in the Orbitrap (resolution 60,000) followed 
by 15 sequential data-dependant collision induced 
dissociation MS2 scans (the threshold value was 
set at 5000 and the minimum injection time was 
set at 200 ms). 
Glycoproteomics. The protein-based approach 
was based on the methodiology described in (28). 
Cells were harvested by centrifugation and 
osmotically lysed at 3.5 x108 cells/ml for 5 min at 
37 oC in the presence of 0.1 µM 1-chloro-3-
tosylamide-7-amino-2-heptone (TLCK), 1mM 
benzamidine, 1mM phenyl-methyl sulfonyl 
fluoride (PMSF), 1 µg/ml leupeptin, 1 µg/ml 
aprotinin and Phosphatase Inhibitor Mixture II 
(Calbiochem). Cell ghosts from a total of 3.5 x 109 
trypanosomes, enriched for non-VSG cellular 
glycoproteins, were collected by centrifugation 
(16,000 g, 15 min, 4oC) and solubilised in 250 µl 
of detergent buffer (4% SDS, 0.1 M DTT, 0.1 M 
Tris-HCl, pH 7.5) using probe sonication for 30 s 
before and after heating to 85oC for 20 min. S-
alkylation was performed by mixing with 250 µl 
of 8 M urea, 0.5 M iodoacetamide (IAA), 0.1 M 
Tris-HCl, pH 8.5, for 1 h, room temperature, in the 
dark. Unreacted IAA was quenched by the 
addition of 10 µl of the detergent buffer. After 
centrifugation (16,000 x g, 15 min) the supernatant 
was transferred to a filtration device with a 30 kDa 
molecular cut-off (Sartorius) and the majority of 
the detergent was removed by diafiltration with 8 
M urea, 0.1 M Tris-HCl, pH 8.5 followed by lectin 
binding buffer (1 mM CaCl2, 1 mM MnCl2, 150 
mM NaCl in 40 mM Tris-HCl, pH 7.4). An aliquot 
(400 µg protein) was mixed with 150 µl packed 
volume of ricin (RCA120)-agarose beads (Vector 
Laboratories) and rotated gently for 2 h. The beads 
were washed with lectin binding buffer and eluted 
with 300 µl of the same buffer containing 30 
mg/ml lactose and 30 mg/ml galactose (Sigma-
Aldrich) in 40 mM Tris-HCl, pH 7.4. After 
overnight incubation, the supernatant containing 
the eluted glycoproteins were collected by 
centrifugation (10,000 x g for 10 min). ConA-
coupled agarose beads (0.15 ml packed volume, 
Vector Laboratories) was added to the recovered 
supernatant from the RCA120 pull-down and 
incubated at 4 oC for overnight. The beads were 
washed with lectin binding buffer and eluted with 
300 µl of 0.5 M methyl-alpha-D-mannopyranoside 
(Sigma) in 40 mM Tris-HCl, pH 7.4. After gentle 
rotation for 2 h the supernatant containing 
glycoproteins were recovered by centrifugation. 
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The RCA120 and ConA eluted glycoproteins were 
mixed, transferred to a 30 kDa filter, the buffer 
exchanged with 25 mM ammonium acetate, pH 
5.5, and subjected to digestion with 180 mU 
endoglycosidase H (EndoH, Roche Applied 
Sciences) overnight at 37 oC. The EndoH released 
glycans were removed by centrifugation and the 
remaining material was exchanged into 40 mM 
ammonium bicarbonate buffer in H2[18O] (Sigma), 
and subsequently digested with 100 units of N-
glycosidase F (PNGaseF, Roche) dissolved in 
H2[18O]. PNGaseF in the presence of H2[18O] 
converts Asn to [18O]Asp with a mass increment of 
2.9890 Da that can be readily distinguished from 
spontaneous deamidation (mass increment of 
0.9858 Da). After overnight incubation at 37 oC, 
the PNGaseF released glycans were removed by 
centrifugation and the deglycosylated proteins 
were diafiltered into 40 mM ammonium 
bicarbonate and subsequently digested with a 
mixture of 1:100 (enzyme: substrate) Lys-C and 
1:20 trypsin (Roche) at 37 oC for 48 h. The 
peptides were collected by centrifugation through 
the filter, dried in Speedvac and desalted using Zip 
Tip C18 micro column (10 µl, Merck Millipore) 
prior liquid chromatography tandem mass 
spectrometry (LC-MS/MS). 
An alternative (glyco)peptide-based approach was 
also performed, based on the method of (77). An 
aliquot of the denatured and S-alkylated sample 
(400 µg) was first digested on a 10 kDa filter with 
a mix of Lys-C and trypsin, as described above. 
The (glyco)peptides were collected by 
centrifugation through the filter in lectin binding 
buffer and were mixed with lectin solution 
containing a mixture of ConA and RCA120 
resulting in mixtures of (glyco)peptides and lectins 
with a mass proportion of 1:2. After gentle rotation 
for 2 h the mixtures were transferred to a 30 kDa 
filter, the lectin-captured glycopeptides were 
diafiltered into 25 mM ammonium acetate, pH 5.5, 
and subjected to EndoH digestion. After overnight 
incubation at 37oC, the EndoH released peptides 
(Asn N-GlcNAc residue) were collected by gentle 
centrifugation. The peptides containing EndoH 
resistant glycans still bound to lectins were 
diafiltered into 40 mM ammonium bicarbonate 
buffer in H2[18O] and digested with PNGaseF 
overnight at 37oC. The de-glycosylated peptides 
were collected by centrifugation, mixed with the 
EndoH released fraction, dried in a Speedvac and 
desalted using ZipTip C18 prior LC-MS/MS, 
which was performed as described above. 
LC-MS/MS analysis and data processing. For 
glycoproteomics, the LC was performed on a fully 
automated Ultimate U3000 Nano LC System 
(Dionex) fitted with a C18 trap- (PepMap 
nanoViper, Thermo Scientific) and resolving 
columns (PepMap RSLC) with inner diameters of 
100 and 75 µm and lengths of 2 and 50 cm, 
respectively. Mobile phases consisted of 0.1% 
formic acid (Sigma) in 2% acetonitrile (Merck, 
Darmstadt Germany) for solvent A and 0.08% 
formic acid in 80% acetonitrile for solvent B. 
Samples were loaded in solvent A. A linear 
gradient was set as follows: 0% B for 5 min, then 
a gradient up to 40% B in 122 min and to 98% B 
in 10 min. A 20 min wash at 98% B is used to keep 
the column sensitive and prevent carryover, and a 
20-min equilibration with 2% B completed the 
gradient. The LC system was coupled to an LTQ-
Orbitrap Velos mass spectrometer (Thermo 
Scientific) equipped with an Easy spray ion source 
and operated in positive ion mode. The spray 
voltage was set to 2 kV, and the ion transfer tube 
at 250 oC. The full scans were acquired in a Fourier 
transform MS mass analyser that covered an m/z 
range of 335-1800 at a resolution of 60 000. The 
MS/MS analysis were performed under data-
dependent mode to fragment the top 15 precursors 
using collision induced dissociation (CID). A 
normalised collision energy of -35 eV, an isolation 
width of m/z 2.0, an activation Q value of 0.250, 
and a time of 100 ms were used. The raw files were 
converted to mgf format by MSConvert software 
from ProteoWizard 
(proteowizard.sourceforge.net). The searches 
were carried out against the T. brucei 927 
annotated proteins database (v.8.0, downloaded 
from TriTrypDB (78), www.tritrypdb.org/) using 
Mascot software (v.2.4.0, Matrix Science Inc., 
Boston, MA). The search parameters for Mascot 
software were set as follows: peptide tolerance, 5 
ppm; MS/MS tolerance, 0.5 Da; enzyme, trypsin; 
one missed cleavage allowed; and fixed 
carbamidomethyl modifications of cysteines. 
Oxidation of methionine, N-acetylglucosamine 
modification of Asn and deamidation of Asn to 
Asp containing a single 18O atom (2.9890 Da mass 
increase) are used as variable modifications. 
Dataset Extraction. We extracted from the 
mascot result files all the peptides with an ion-
score >20. From this we selected 350 glycosylated 
sites with a deamidation (Asn to [18O]Asp 
conversion) or Asn-N-HexNAc modification 
embedded in the N.^P[ST] consensus. The list was 
used to count the number of times (>=3) that these 
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changes were detected for each peptide. To 
increase the number of modified peptides we 
decided to re-process a previously published work 
in our laboratory (28). This dataset was re-
searched with the same mascot parameters and 
database used for this publication. This made it 
possible to include 14 new peptides preferentially 
HexNac modified and compile a list of 186 
peptides used for the next phase of machine 
learning implemented in python with the scikit-
learn package (79). 
The data set reported here and that from (28) 
identified 170 common and 180 and 155 unique 
glycosylation sites, respectively (Fig S1A).  To 
check the consistency of the two datasets, we 
selected 92 peptides that were observed >= 4 times 
in both datasets and plotted the frequencies of the 
Asn-N-HexNAc and Asn to [18O]Asp 
modifications. The two datasets had a good 
correlation (r2 = 0.83) (Fig S1B). However, the 
experimental procedures used to generate the 2009 
dataset (i.e., without the use of H218O) cannot 
discriminate between the spontaneous non-
enzymatic deamidation of asparagine to aspartic 
acid versus the PNGaseF-mediated deamidation 
produced during the cleavage of the N-glycan. 
From the linear regression, we could deduce that 
non-enzymatic deamidation contributed a 
significant amount (about 18%) of the total 
deamidation seen in the 2009 dataset (Fig S1B). 
For this reason, we only used Asn-N-HexNAc 
containing (TbSTT3B substrate) peptides (with a 
frequency of >= 0.6) from this dataset to augment 
our machine learning training set.  
Machine Learning. The deamidation proportion 
(DP) was computed for each peptide as (DC / DC 
+ HC) where DC is the Deamidation Count (i.e., 
the number of times a peptide with [18O]Asp is 
detected) and HC is the HexNAc Count (i.e., the 
number of times a peptide with Asn-N-HexNAc is 
detected). This score was used to classify each 
peptide as preferentially deamidated (score>0.8 
n=70) or preferentially HexNac modified 
(score<0.3% n=56). This dataset was used to 
extract sequence based feature from 10 amino 
acids before and after the glycosylated asparagine 
with the ASAP package in Python (80). We also 
added some in-house features derived from the 
knowledge of the TbSTT3A recognition and 
transfer experiment reported in (Figure 4B and 
Table 1). To this end we created ‘Bonus Features’ 
for each residue position probed in that experiment 
based on the increased transfer efficiency observed 
when that site is occupied by an Asp (or, by 
inference, a Glu residue). We also included a 
‘Bonus All’ feature that summed all of the bonus 
scores for the peptide when it contained more than 
one Asp and/or Glu residue and a ‘Bonus Max’ 
feature that selected only the highest bonus score 
in such cases. Finally, we also created ‘Bonus 
Presence D’ and ‘Bonus Presence E’ features that 
simply recorded the presence or absence of Asp or 
Glu, respectively, at each residue location. We 
then developed three machine learning algorithms: 
a random forest classifier (RFC), an extra tree 
classifier (ETC) and a support vector machine 
classifier (SVM). The predictors were used to 
extract the importance of all the features and to 
rank the features with recursive feature elimination 
and cross-validated selection of the best number of 
features (RFECV methodology). The selected 
features were used to train the three machine 
learning algorithms (RFC, ETC, SVM) that were 
further optimized using a Bayesian global 
optimization with Gaussian processes 
(https://github.com/fmfn/BayesianOptimization). 
The optimized machine learning algorithms were 
combined in a voting classifier to produce our final 
predictor. The ability of the developed classifiers 
(RFC, ETC, SVM and Voting Classifier) to 
discriminate between the deamidated or HexNac 
modified peptides was assessed with the area 
under the curve (AUC) of the receiver operating 
characteristic (ROC) curve. The AUC score was 
computed 100 times with a five-fold cross 
validation, using each time a different random split 
of the original dataset (Figure S5). 
CONFLICTS OF INTEREST: The authors 
declare that they have no conflicts of interest with 
the contents of this article.  
AUTHOR CONTRIBUTIONS: M.A.J.F. 
conceived and coordinated the study. A.J., L.A., 
and M.A.J.F. designed the experiments.  A.J. 
performed the biochemical, SILAC proteomic and 
molecular modelling experiments. L.A. performed 
the glycoproteomic experiments. M.T.  performed 
the bioinformatic analyses and designed the 
machine–learning experiments.  
ACKNOWLEDGEMENTS: This work was 
supported by a Wellcome Trust Investigator 
Award to M.A.J.F. (101842). Wellcome Trust 
grant 097045/B/11/Z provided mass 
spectrometry and proteomics infrastructure 
support. A.J. thanks the School of Life Sciences, 
University of Dundee, for a PhD studentship. We 
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 13 
thank the Dundee Proteomics facility team for 
their help and Amy Tavendale for assistance 
with processing the SILAC data. We thank 
Angela Mehlert, Lucia Güther, Mick Urbaniak 
and Jim Proctor for helpful advice and comments 
and Markus Aebi for helpful discussions and 
kindly sharing information prior to publication.  
  
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 14 
 
REFERENCES 
1. Schwede, A., Macleod, O. J. S., MacGregor, P., and Carrington, M. (2015) How Does the VSG 
Coat of Bloodstream Form African Trypanosomes Interact with External Proteins? PLoS 
Pathog 11, e1005259 
2. Horn, D. (2014) Antigenic variation in African trypanosomes. Mol Biochem Parasitol 195, 
123-129 
3. Salmon, D., Geuskens, M., Hanocq, F., Hanocq-Quertier, J., Nolan, D., Ruben, L., and Pays, E. 
(1994) A novel heterodimeric transferrin receptor encoded by a pair of VSG expression site-
associated genes in T. brucei. Cell 78, 75-86 
4. Steverding, D. (2000) The transferrin receptor of Trypanosoma brucei. Parasitol Int 48, 191-
198 
5. Mehlert, A., Wormald, M. R., and Ferguson, M. A. J. (2012) Modeling of the N-glycosylated 
transferrin receptor suggests how transferrin binding can occur within the surface coat of 
Trypanosoma brucei. PLoS Pathog 8, e1002618 
6. Peck, R. F., Shiflett, A. M., Schwartz, K. J., McCann, A., Hajduk, S. L., and Bangs, J. D. (2008) 
The LAMP-like protein p67 plays an essential role in the lysosome of African trypanosomes. 
Mol Microbiol 68, 933-946 
7. Jackson, A. P., Allison, H. C., Barry, J. D., Field, M. C., Hertz-Fowler, C., and Berriman, M. 
(2013) A cell-surface phylome for African trypanosomes. PLoS Negl Trop Dis 7, e2121 
8. Allison, H., O'Reilly, A. J., Sternberg, J., and Field, M. C. (2014) An extensive endoplasmic 
reticulum-localised glycoprotein family in trypanosomatids. Microb Cell 1, 325-345 
9. Lingnau, A., Zufferey, R., Lingnau, M., and Russell, D. G. (1999) Characterization of tGLP-1, a 
Golgi and lysosome-associated, transmembrane glycoprotein of African trypanosomes. J Cell 
Sci 112 Pt 18, 3061-3070 
10. Engstler, M., Weise, F., Bopp, K., Grunfelder, C. G., Gunzel, M., Heddergott, N., and Overath, 
P. (2005) The membrane-bound histidine acid phosphatase TbMBAP1 is essential for 
endocytosis and membrane recycling in Trypanosoma brucei. J Cell Sci 118, 2105-2118 
11. LaCount, D. J., Barrett, B., and Donelson, J. E. (2002) Trypanosoma brucei FLA1 is required 
for flagellum attachment and cytokinesis. J Biol Chem 277, 17580-17588 
12. Treumann, A., Zitzmann, N., Hulsmeier, A., Prescott, A. R., Almond, A., Sheehan, J., and 
Ferguson, M. A. (1997) Structural characterisation of two forms of procyclic acidic repetitive 
protein expressed by procyclic forms of Trypanosoma brucei. J Mol Biol 269, 529-547 
13. Acosta-Serrano, A., Cole, R. N., Mehlert, A., Lee, M. G., Ferguson, M. A., and Englund, P. T. 
(1999) The procyclin repertoire of Trypanosoma brucei. Identification and structural 
characterization of the Glu-Pro-rich polypeptides. J Biol Chem 274, 29763-29771 
14. Guther, M. L., Lee, S., Tetley, L., Acosta-Serrano, A., and Ferguson, M. A. (2006) GPI-
anchored proteins and free GPI glycolipids of procyclic form Trypanosoma brucei are 
nonessential for growth, are required for colonization of the tsetse fly, and are not the only 
components of the surface coat. Mol Biol Cell 17, 5265-5274 
15. Guther, M. L., Beattie, K., Lamont, D. J., James, J., Prescott, A. R., and Ferguson, M. A. (2009) 
Fate of glycosylphosphatidylinositol (GPI)-less procyclin and characterization of sialylated 
non-GPI-anchored surface coat molecules of procyclic-form Trypanosoma brucei. Eukaryot 
Cell 8, 1407-1417 
16. Zamze, S. E., Wooten, E. W., Ashford, D. A., Ferguson, M. A., Dwek, R. A., and Rademacher, T. 
W. (1990) Characterisation of the asparagine-linked oligosaccharides from Trypanosoma 
brucei type-I variant surface glycoproteins. Eur J Biochem 187, 657-663 
17. Zamze, S. E., Ashford, D. A., Wooten, E. W., Rademacher, T. W., and Dwek, R. A. (1991) 
Structural characterization of the asparagine-linked oligosaccharides from Trypanosoma 
brucei type II and type III variant surface glycoproteins. J Biol Chem 266, 20244-20261 
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 15 
18. Atrih, A., Richardson, J. M., Prescott, A. R., and Ferguson, M. A. J. (2005) Trypanosoma brucei 
glycoproteins contain novel giant poly-N-acetyllactosamine carbohydrate chains. J Biol Chem 
280, 865-871 
19. Izquierdo, L., Atrih, A., Rodrigues, J. A., Jones, D. C., and Ferguson, M. A. J. (2009) 
Trypanosoma brucei UDP-glucose:glycoprotein glucosyltransferase has unusual substrate 
specificity and protects the parasite from stress. Eukaryotic cell 8, 230-240 
20. Bandini, G., Marino, K., Guther, M. L., Wernimont, A. K., Kuettel, S., Qiu, W., Afzal, S., Kelner, 
A., Hui, R., and Ferguson, M. A. (2012) Phosphoglucomutase is absent in Trypanosoma brucei 
and redundantly substituted by phosphomannomutase and phospho-N-acetylglucosamine 
mutase. Mol Microbiol 85, 513-534 
21. Bangs, J. D., Doering, T. L., Englund, P. T., and Hart, G. W. (1988) Biosynthesis of a variant 
surface glycoprotein of Trypanosoma brucei. Processing of the glycolipid membrane anchor 
and N-linked oligosaccharides. J Biol Chem 263, 17697-17705 
22. Aebi, M. (2013) N-linked protein glycosylation in the ER. Biochim Biophys Acta 1833, 2430-
2437 
23. Cherepanova, N., Shrimal, S., and Gilmore, R. (2016) N-linked glycosylation and homeostasis 
of the endoplasmic reticulum. Curr Opin Cell Biol 41, 57-65 
24. Acosta-Serrano, A., O'Rear, J., Quellhorst, G., Lee, S. H., Hwa, K. Y., Krag, S. S., and Englund, 
P. T. (2004) Defects in the N-linked oligosaccharide biosynthetic pathway in a Trypanosoma 
brucei glycosylation mutant. Eukaryot Cell 3, 255-263 
25. Manthri, S., Guther, M. L., Izquierdo, L., Acosta-Serrano, A., and Ferguson, M. A. (2008) 
Deletion of the TbALG3 gene demonstrates site-specific N-glycosylation and N-glycan 
processing in Trypanosoma brucei. Glycobiology 18, 367-383 
26. Jones, D. C., Mehlert, A., Guther, M. L., and Ferguson, M. A. (2005) Deletion of the 
glucosidase II gene in Trypanosoma brucei reveals novel N-glycosylation mechanisms in the 
biosynthesis of variant surface glycoprotein. J Biol Chem 280, 35929-35942 
27. Izquierdo, L., Mehlert, A., and Ferguson, M. A. J. (2012) The lipid-linked oligosaccharide 
donor specificities of Trypanosoma brucei oligosaccharyltransferases. Glycobiology 22, 696-
703 
28. Izquierdo, L., Schulz, B. L., Rodrigues, J. A., Guther, M. L., Procter, J. B., Barton, G. J., Aebi, M., 
and Ferguson, M. A. (2009) Distinct donor and acceptor specificities of Trypanosoma brucei 
oligosaccharyltransferases. EMBO J 28, 2650-2661 
29. Castro, O., Movsichoff, F., and Parodi, A. J. (2006) Preferential transfer of the complete 
glycan is determined by the oligosaccharyltransferase complex and not by the catalytic 
subunit. Proc Natl Acad Sci U S A 103, 14756-14760 
30. Kelleher, D. J., Banerjee, S., Cura, A. J., Samuelson, J., and Gilmore, R. (2007) Dolichol-linked 
oligosaccharide selection by the oligosaccharyltransferase in protist and fungal organisms. J 
Cell Biol 177, 29-37 
31. Nasab, F. P., Schulz, B. L., Gamarro, F., Parodi, A. J., and Aebi, M. (2008) All in one: 
Leishmania major STT3 proteins substitute for the whole oligosaccharyltransferase complex 
in Saccharomyces cerevisiae. Molecular biology of the cell 19, 3758-3768 
32. Hese, K., Otto, C., Routier, F. H., and Lehle, L. (2009) The yeast oligosaccharyltransferase 
complex can be replaced by STT3 from Leishmania major. Glycobiology 19, 160-171 
33. Izquierdo, L., Atrih, A., Rodrigues, J. A., Jones, D. C., and Ferguson, M. A. (2009) Trypanosoma 
brucei UDP-glucose:glycoprotein glucosyltransferase has unusual substrate specificity and 
protects the parasite from stress. Eukaryot Cell 8, 230-240 
34. Damerow, M., Rodrigues, J. A., Wu, D., Guther, M. L., Mehlert, A., and Ferguson, M. A. 
(2014) Identification and functional characterization of a highly divergent N-
acetylglucosaminyltransferase I (TbGnTI) in Trypanosoma brucei. J Biol Chem 289, 9328-9339 
35. Damerow, M., Graalfs, F., Guther, M. L., Mehlert, A., Izquierdo, L., and Ferguson, M. A. 
(2016) A Gene of the beta3-Glycosyltransferase Family Encodes N-
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 16 
Acetylglucosaminyltransferase II Function in Trypanosoma brucei. J Biol Chem 291, 13834-
13845 
36. Urbaniak, M. D., Martin, D. M., and Ferguson, M. A. (2013) Global quantitative SILAC 
phosphoproteomics reveals differential phosphorylation is widespread between the 
procyclic and bloodstream form lifecycle stages of Trypanosoma brucei. Journal of proteome 
research 12, 2233-2244 
37. Bangs, J. D., Brouch, E. M., Ransom, D. M., and Roggy, J. L. (1996) A soluble secretory 
reporter system in Trypanosoma brucei. Studies on endoplasmic reticulum targeting. J Biol 
Chem 271, 18387-18393 
38. Wirtz, E., Leal, S., Ochatt, C., and Cross, G. A. (1999) A tightly regulated inducible expression 
system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma 
brucei. Mol Biochem Parasitol 99, 89-101 
39. Mehlert, A., Sullivan, L., and Ferguson, M. A. J. (2010) Glycotyping of Trypanosoma brucei 
variant surface glycoprotein MITat1.8. Mol Biochem Parasitol 174, 74-77 
40. Cardoso de Almeida, M. L., and Turner, M. J. (1983) The membrane form of variant surface 
glycoproteins of Trypanosoma brucei. Nature 302, 349-352 
41. Ferguson, M. A., Haldar, K., and Cross, G. A. (1985) Trypanosoma brucei variant surface 
glycoprotein has a sn-1,2-dimyristyl glycerol membrane anchor at its COOH terminus. J Biol 
Chem 260, 4963-4968 
42. Crooks, G. E., Hon, G., Chandonia, J. M., and Brenner, S. E. (2004) WebLogo: a sequence logo 
generator. Genome Res 14, 1188-1190 
43. Vacic, V., Iakoucheva, L. M., and Radivojac, P. (2006) Two Sample Logo: a graphical 
representation of the differences between two sets of sequence alignments. Bioinformatics 
22, 1536-1537 
44. Miller, M. L., Jensen, L. J., Diella, F., Jorgensen, C., Tinti, M., Li, L., Hsiung, M., Parker, S. A., 
Bordeaux, J., Sicheritz-Ponten, T., Olhovsky, M., Pasculescu, A., Alexander, J., Knapp, S., 
Blom, N., Bork, P., Li, S., Cesareni, G., Pawson, T., Turk, B. E., Yaffe, M. B., Brunak, S., and 
Linding, R. (2008) Linear motif atlas for phosphorylation-dependent signaling. Science 
signaling 1, ra2 
45. Poljak. (2017) Analysis of Substrate Specificity of Trypanosoma brucei OSTs by Functional 
Expression in Yeast, Submitted. JBC  
46. Kelley, L. A., Mezulis, S., Yates, C. M., Wass, M. N., and Sternberg, M. J. (2015) The Phyre2 
web portal for protein modeling, prediction and analysis. Nat Protoc 10, 845-858 
47. Lizak, C., Gerber, S., Numao, S., Aebi, M., and Locher, K. P. (2011) X-ray structure of a 
bacterial oligosaccharyltransferase. Nature 474, 350-355 
48. Krissinel, E., and Henrick, K. (2004) Secondary-structure matching (SSM), a new tool for fast 
protein structure alignment in three dimensions. Acta crystallographica. Section D, Biological 
crystallography 60, 2256-2268 
49. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., and 
Ferrin, T. E. (2004) UCSF Chimera--a visualization system for exploratory research and 
analysis. Journal of computational chemistry 25, 1605-1612 
50. Kalb, L. C., Frederico, Y. C., Boehm, C., Moreira, C. M., Soares, M. J., and Field, M. C. (2016) 
Conservation and divergence within the clathrin interactome of Trypanosoma cruzi. Sci Rep 
6, 31212 
51. Manna, P. T., Obado, S. O., Boehm, C., Gadelha, C., Sali, A., Chait, B. T., Rout, M. P., and Field, 
M. C. (2017) Lineage-specific proteins essential for endocytosis in trypanosomes. J Cell Sci 
130, 1379-1392 
52. Boehm, C. M., Obado, S., Gadelha, C., Kaupisch, A., Manna, P. T., Gould, G. W., Munson, M., 
Chait, B. T., Rout, M. P., and Field, M. C. (2017) The Trypanosome Exocyst: A Conserved 
Structure Revealing a New Role in Endocytosis. PLoS Pathog 13, e1006063 
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 17 
53. Obado, S. O., Brillantes, M., Uryu, K., Zhang, W., Ketaren, N. E., Chait, B. T., Field, M. C., and 
Rout, M. P. (2016) Interactome Mapping Reveals the Evolutionary History of the Nuclear 
Pore Complex. PLoS Biol 14, e1002365 
54. Maishman, L., Obado, S. O., Alsford, S., Bart, J. M., Chen, W. M., Ratushny, A. V., Navarro, 
M., Horn, D., Aitchison, J. D., Chait, B. T., Rout, M. P., and Field, M. C. (2016) Co-dependence 
between trypanosome nuclear lamina components in nuclear stability and control of gene 
expression. Nucleic Acids Res 44, 10554-10570 
55. Nagamune, K., Ohishi, K., Ashida, H., Hong, Y., Hino, J., Kangawa, K., Inoue, N., Maeda, Y., 
and Kinoshita, T. (2003) GPI transamidase of Trypanosoma brucei has two previously 
uncharacterized (trypanosomatid transamidase 1 and 2) and three common subunits. Proc 
Natl Acad Sci U S A 100, 10682-10687 
56. Choi, B. K., Warburton, S., Lin, H., Patel, R., Boldogh, I., Meehl, M., d'Anjou, M., Pon, L., 
Stadheim, T. A., and Sethuraman, N. (2012) Improvement of N-glycan site occupancy of 
therapeutic glycoproteins produced in Pichia pastoris. Appl Microbiol Biotechnol 95, 671-682 
57. Yan, A., Wu, E., and Lennarz, W. J. (2005) Studies of yeast oligosaccharyl transferase subunits 
using the split-ubiquitin system: topological features and in vivo interactions. Proc Natl Acad 
Sci U S A 102, 7121-7126 
58. Ferguson, M. A., Duszenko, M., Lamont, G. S., Overath, P., and Cross, G. A. (1986) 
Biosynthesis of Trypanosoma brucei variant surface glycoproteins. N-glycosylation and 
addition of a phosphatidylinositol membrane anchor. J Biol Chem 261, 356-362 
59. Siegel, T. N., Hekstra, D. R., Wang, X., Dewell, S., and Cross, G. A. (2010) Genome-wide 
analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and 
identification of splicing and polyadenylation sites. Nucleic Acids Res 38, 4946-4957 
60. Butter, F., Bucerius, F., Michel, M., Cicova, Z., Mann, M., and Janzen, C. J. (2013) 
Comparative proteomics of two life cycle stages of stable isotope-labeled Trypanosoma 
brucei reveals novel components of the parasite's host adaptation machinery. Molecular & 
cellular proteomics : MCP 12, 172-179 
61. Urbaniak, M. D., Guther, M. L., and Ferguson, M. A. (2012) Comparative SILAC proteomic 
analysis of Trypanosoma brucei bloodstream and procyclic lifecycle stages. PloS one 7, 
e36619 
62. Castillo-Acosta, V. M., Ruiz-Perez, L. M., Etxebarria, J., Reichardt, N. C., Navarro, M., Igarashi, 
Y., Liekens, S., Balzarini, J., and Gonzalez-Pacanowska, D. (2016) Carbohydrate-Binding Non-
Peptidic Pradimicins for the Treatment of Acute Sleeping Sickness in Murine Models. PLoS 
Pathog 12, e1005851 
63. Castillo-Acosta, V. M., Ruiz-Perez, L. M., Van Damme, E. J., Balzarini, J., and Gonzalez-
Pacanowska, D. (2015) Exposure of Trypanosoma brucei to an N-acetylglucosamine-binding 
lectin induces VSG switching and glycosylation defects resulting in reduced infectivity. PLoS 
Negl Trop Dis 9, e0003612 
64. Castillo-Acosta, V. M., Vidal, A. E., Ruiz-Perez, L. M., Van Damme, E. J., Igarashi, Y., Balzarini, 
J., and Gonzalez-Pacanowska, D. (2013) Carbohydrate-binding agents act as potent 
trypanocidals that elicit modifications in VSG glycosylation and reduced virulence in 
Trypanosoma brucei. Mol Microbiol 90, 665-679 
65. Ruiz-Canada, C., Kelleher, D. J., and Gilmore, R. (2009) Cotranslational and posttranslational 
N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell 136, 272-283 
66. Shrimal, S., Cherepanova, N. A., and Gilmore, R. (2015) Cotranslational and 
posttranslocational N-glycosylation of proteins in the endoplasmic reticulum. Semin Cell Dev 
Biol 41, 71-78 
67. Shrimal, S., Cherepanova, N. A., and Gilmore, R. (2015) Cotranslational and 
posttranslocational N-glycosylation of proteins in the endoplasmic reticulum. Seminars in 
cell & developmental biology 41, 71-78 
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 18 
68. Cherepanova, N., Shrimal, S., and Gilmore, R. (2016) N-linked glycosylation and homeostasis 
of the endoplasmic reticulum. Current opinion in cell biology 41, 57-65 
69. Cherepanova, N. A., Shrimal, S., and Gilmore, R. (2014) Oxidoreductase activity is necessary 
for N-glycosylation of cysteine-proximal acceptor sites in glycoproteins. J Cell Biol 206, 525-
539 
70. Mohorko, E., Owen, R. L., Malojcic, G., Brozzo, M. S., Aebi, M., and Glockshuber, R. (2014) 
Structural basis of substrate specificity of human oligosaccharyl transferase subunit 
N33/Tusc3 and its role in regulating protein N-glycosylation. Structure 22, 590-601 
71. Schulz, B. L., Stirnimann, C. U., Grimshaw, J. P., Brozzo, M. S., Fritsch, F., Mohorko, E., 
Capitani, G., Glockshuber, R., Grutter, M. G., and Aebi, M. (2009) Oxidoreductase activity of 
oligosaccharyltransferase subunits Ost3p and Ost6p defines site-specific glycosylation 
efficiency. Proc Natl Acad Sci U S A 106, 11061-11066 
72. Schulz, B. L., and Aebi, M. (2009) Analysis of glycosylation site occupancy reveals a role for 
Ost3p and Ost6p in site-specific N-glycosylation efficiency. Molecular & cellular proteomics : 
MCP 8, 357-364 
73. Woycechowsky, K. J., and Raines, R. T. (2003) The CXC motif: a functional mimic of protein 
disulfide isomerase. Biochemistry 42, 5387-5394 
74. Tiengwe, C., Muratore, K. A., and Bangs, J. D. (2016) Surface proteins, ERAD and antigenic 
variation in Trypanosoma brucei. Cell Microbiol 18, 1673-1688 
75. Hirumi, H., and Hirumi, K. (1989) Continuous cultivation of Trypanosoma brucei blood 
stream forms in a medium containing a low concentration of serum protein without feeder 
cell layers. J Parasitol 75, 985-989 
76. Oberholzer, M., Morand, S., Kunz, S., and Seebeck, T. (2006) A vector series for rapid PCR-
mediated C-terminal in situ tagging of Trypanosoma brucei genes. Mol Biochem Parasitol 
145, 117-120 
77. Zielinska, D. F., Gnad, F., Wisniewski, J. R., and Mann, M. (2010) Precision mapping of an in 
vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141, 897-907 
78. Aslett, M., Aurrecoechea, C., Berriman, M., Brestelli, J., Brunk, B. P., Carrington, M., 
Depledge, D. P., Fischer, S., Gajria, B., Gao, X., Gardner, M. J., Gingle, A., Grant, G., Harb, O. 
S., Heiges, M., Hertz-Fowler, C., Houston, R., Innamorato, F., Iodice, J., Kissinger, J. C., 
Kraemer, E., Li, W., Logan, F. J., Miller, J. A., Mitra, S., Myler, P. J., Nayak, V., Pennington, C., 
Phan, I., Pinney, D. F., Ramasamy, G., Rogers, M. B., Roos, D. S., Ross, C., Sivam, D., Smith, D. 
F., Srinivasamoorthy, G., Stoeckert, C. J., Jr., Subramanian, S., Thibodeau, R., Tivey, A., 
Treatman, C., Velarde, G., and Wang, H. (2010) TriTrypDB: a functional genomic resource for 
the Trypanosomatidae. Nucleic Acids Res 38, D457-462 
79. Abraham, A., Pedregosa, F., Eickenberg, M., Gervais, P., Mueller, A., Kossaifi, J., Gramfort, A., 
Thirion, B., and Varoquaux, G. (2014) Machine learning for neuroimaging with scikit-learn. 
Front Neuroinform 8, 14 
80. Brandes, N., Ofer, D., and Linial, M. (2016) ASAP: a machine learning framework for local 
protein properties. Database (Oxford) 2016 
 
 
 
 
 
 
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 19 
FIGURE LEGENDS: 
Figure 1. Denaturing and blue native gel electrophoresis of TbSTT3A-HA3. SDS-PAGE 
and anti-HA Western blotting (panel A) or blue native gel electrophoresis and anti-HA Western 
blotting (panel B) of anti-HA/protein G magnetic bead pull-outs from digitonin lysates of wild-
type (lane 1) and in situ TbSTT3A-HA3 tagged (lane 2) bloodstream form trypanosomes.  
 
Figure 2. Overview of the SILAC pull-out experiment and plot of proteomics data. Panel 
A: Overview of the SILAC experiment. Wild-type bloodstream form cells were grown in light 
(R0K0) medium, and cells expressing in situ-tagged TbSTT3A-HA3 were labelled with heavy 
(R6K4) medium. The cells were mixed 1:1 and TbSTT3A-HA3 was enriched by affinity-
selection on anti-HA magnetic beads. Peptides from TbSTT3A-HA3 and genuine binding 
proteins have high heavy/light isotope ratios, whereas those from contaminants will have ratios 
close to 1:1 (Log2 = 0). Panel B: Results from the TbSTT3A SILAC pull-out experiment. The 
plot shows the Log2 of the heavy-to-light isotope ratio (x axis) versus the Log10 value of the 
intensities of the peptides belonging to each protein that was detected (y axis). The black curves 
(marked sigma 3) represent three standard deviations from the mean. Proteins plotted in orange 
have a heavy-to-light ratio above the sigma 3 cut off and are significantly enriched. TbSTT3A-
HA3 (bait) and TbSTT3B (both annotated) were shown to be highly enriched and are 
highlighted in red. Panel C: Results from the TbSTT3B-MYC3 SILAC pull-out experiment. 
The plot is the same as in panel B except that in situ-tagged TbSTT3B-MYC3 was used as bait. 
Again, TbSTT3A and TbSTT3A (both annotated and highlighted in red) were significantly 
enriched.  
 
Figure 3. Co-immunoprecipitation of TbSTT3A and TbSTT3B. Digitonin lysates from wild 
type cells (lanes 1, 3, 5 and 7) and TbSTT3A-HA3 and TbSTT3B-MYC3 double in-situ tagged 
cells (lanes 2, 4, 6 and 8) were subjected to IP and Western blotted with anti-HA or anti-MYC 
antibodies, as indicated. The red rectangles highlight the bands corresponding to TbSTT3A-
HA3 (lanes 2 and 4) and TbSTT3B-MYC3 (lanes 6 and 8).  
Figure 4. In vivo assay of TbSTT3A substrate specificity. Panel A: The constructs described 
in (Table 1) were expressed in bloodstream form trypanosomes and the resulting TbBiPN-
[XXXXXNXTXXXXX]-HA3 reporter glycoproteins were visualised in cell lysates by SDS-
PAGE and anti-HA Western blotting. Representative examples are shown for the sequences 
indicated (lanes 1-3). The proportions of the anti-HA signals that were sensitive (lower bands) 
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and resistant (upper bands) to EndoH were quantified and are reported in (Table 1). Panel B: 
Summary of the quantitative data from (Table 1) showing the influence of replacing single 
neutral Ala residues with an acidic Asp residue at each possible position.  
 
Figure 5. Glycoproteomic data logos and predictor. The amino acid frequencies of the 
preferentially deamidated (A) or preferentially HexNAc modified peptides (B) identified by 
mass spectrometry are visualized with the WebLogo web service. The Two Sample logo web 
service was used to visualize the amino acids enriched (upper part) or depleted (lower part) in 
the sequences of the preferentially deamidated peptides identified by mass spectrometry (C) or 
predicted by the machine learning algorithm (D) by using the preferentially HexNAc modified 
peptides as negative sample.  
Figure 6. Molecular models of the active sites of TbSTT3A and TbSTT3B. Molecular 
models of the predicted active sites of TbSTT3A (panel A) and TbSTT3B (panel B) with an 
acceptor peptide (GDQNAT) based on the crystal structure of C. lari PglB (Lizak et al., 2011). 
Of note are the residues in red: Arg397 in TbSTT3A (His397 in TbSTT3B) and Arg406 in 
TbSTT3A (Gly406 in TbSTT3B), where the guanidinium cations of the Arg sidechains could 
interact with acidic residues at or close to the acceptor peptide sequon.  
 
 
 
 
 
 
 
 
 
 
 at U
N
IV
ERSITY
 O
F D
U
N
D
EE on O
ctober 5, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 21 
Table 1. Effect of aspartic acid on glycosite recognition by TbSTT3A.  
Name Sequence pI % EndoH-resistant 
(% STT3A transfer)a 
Alanine control (Ala) AAAAANATAAAAA 6.01 6.8±3.7 
D -5 DAAAANATAAAAA 3.10 34.4±6.1 
D -4 ADAAANATAAAAA 3.10 44.8±8.9 
D -3 AADAANATAAAAA 3.10 36.9±2.6 
D -2 AAADANATAAAAA 3.10 36.5±7.2 
D -1 AAAADNATAAAAA 3.10 70.5±1.1 
D +1 AAAAANDTAAAAA 3.10 61.0±11.3 
D +3 AAAAANATDAAAA 3.10 24.0±2.7 
D +4 AAAAANATADAAA 3.10 16.4±4.8 
D +5 AAAAANATAADAA 3.10 21.6±4.4 
D +6 AAAAANATAAADA 3.10 27.2±5.8 
D +7 AAAAANATAAAAD 3.10 10.7±3.1 
 
aThese mean and standard deviation of the mean figures are based on n=8 from two technical 
replicates of 3 biological replicates.  
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